163 related articles for article (PubMed ID: 16319409)
21. Treatment of suicide attempters with bipolar disorder: a randomized clinical trial comparing lithium and valproate in the prevention of suicidal behavior.
Oquendo MA; Galfalvy HC; Currier D; Grunebaum MF; Sher L; Sullivan GM; Burke AK; Harkavy-Friedman J; Sublette ME; Parsey RV; Mann JJ
Am J Psychiatry; 2011 Oct; 168(10):1050-6. PubMed ID: 21768611
[TBL] [Abstract][Full Text] [Related]
22. Effects of divalproex versus lithium on length of hospital stay among patients with bipolar disorder.
Dalkilic A; Diaz E; Baker CB; Pearsall HR; Woods SW
Psychiatr Serv; 2000 Sep; 51(9):1184-6. PubMed ID: 10970927
[TBL] [Abstract][Full Text] [Related]
23. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial.
; Geddes JR; Goodwin GM; Rendell J; Azorin JM; Cipriani A; Ostacher MJ; Morriss R; Alder N; Juszczak E
Lancet; 2010 Jan; 375(9712):385-95. PubMed ID: 20092882
[TBL] [Abstract][Full Text] [Related]
24. Lithium, anticonvulsants and suicidal behavior in bipolar disorder.
Yerevanian BI; Koek RJ; Mintz J
J Affect Disord; 2003 Feb; 73(3):223-8. PubMed ID: 12547290
[TBL] [Abstract][Full Text] [Related]
25. Differential lithium efficacy in reducing suicidal behaviors compared with suicidal thoughts.
Gould TD; Can A; Gottesman II; Courtet P
Am J Psychiatry; 2012 Jan; 169(1):98-9; author reply 99. PubMed ID: 22223017
[No Abstract] [Full Text] [Related]
26. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN
Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
[TBL] [Abstract][Full Text] [Related]
27. Bipolar pharmacotherapy and suicidal behavior. Part I: Lithium, divalproex and carbamazepine.
Yerevanian BI; Koek RJ; Mintz J
J Affect Disord; 2007 Nov; 103(1-3):5-11. PubMed ID: 17628692
[TBL] [Abstract][Full Text] [Related]
28. The role of mood stabilisers in the treatment of the depressive facet of bipolar disorders.
Bourin M; Prica C
Neurosci Biobehav Rev; 2007; 31(6):963-75. PubMed ID: 17462734
[TBL] [Abstract][Full Text] [Related]
29. Divalproex, lithium and suicide among Medicaid patients with bipolar disorder.
Collins JC; McFarland BH
J Affect Disord; 2008 Apr; 107(1-3):23-8. PubMed ID: 17707087
[TBL] [Abstract][Full Text] [Related]
30. Self-harm, Unintentional Injury, and Suicide in Bipolar Disorder During Maintenance Mood Stabilizer Treatment: A UK Population-Based Electronic Health Records Study.
Hayes JF; Pitman A; Marston L; Walters K; Geddes JR; King M; Osborn DP
JAMA Psychiatry; 2016 Jun; 73(6):630-7. PubMed ID: 27167638
[TBL] [Abstract][Full Text] [Related]
31. The new lithium clinic.
Osher Y; Bersudsky Y; Belmaker RH
Neuropsychobiology; 2010; 62(1):17-26. PubMed ID: 20453531
[TBL] [Abstract][Full Text] [Related]
32. Cost effectiveness of strategies to combat neuropsychiatric conditions in sub-Saharan Africa and South East Asia: mathematical modelling study.
Chisholm D; Saxena S
BMJ; 2012 Mar; 344():e609. PubMed ID: 22389339
[TBL] [Abstract][Full Text] [Related]
33. Long-term effectiveness and cost of a systematic care program for bipolar disorder.
Simon GE; Ludman EJ; Bauer MS; Unützer J; Operskalski B
Arch Gen Psychiatry; 2006 May; 63(5):500-8. PubMed ID: 16651507
[TBL] [Abstract][Full Text] [Related]
34. The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample.
Oedegaard KJ; Alda M; Anand A; Andreassen OA; Balaraman Y; Berrettini WH; Bhattacharjee A; Brennand KJ; Burdick KE; Calabrese JR; Calkin CV; Claasen A; Coryell WH; Craig D; DeModena A; Frye M; Gage FH; Gao K; Garnham J; Gershon E; Jakobsen P; Leckband SG; McCarthy MJ; McInnis MG; Maihofer AX; Mertens J; Morken G; Nievergelt CM; Nurnberger J; Pham S; Schoeyen H; Shekhtman T; Shilling PD; Szelinger S; Tarwater B; Yao J; Zandi PP; Kelsoe JR
BMC Psychiatry; 2016 May; 16():129. PubMed ID: 27150464
[TBL] [Abstract][Full Text] [Related]
35. The rapid suicide protection of mood stabilizers on patients with bipolar disorder: A nationwide observational cohort study in Taiwan.
Tsai CJ; Cheng C; Chou PH; Lin CH; McInnis MG; Chang CL; Lan TH
J Affect Disord; 2016 May; 196():71-7. PubMed ID: 26919054
[TBL] [Abstract][Full Text] [Related]
36. Estimation of resource utilisation difference between lithium and valproate treatment groups from the VALID study.
Li SC; Aggarwal SK
J Med Econ; 2011; 14(3):350-6. PubMed ID: 21542675
[TBL] [Abstract][Full Text] [Related]
37. Lithium in bipolar mood disorder.
Dinan TG
BMJ; 2002 Apr; 324(7344):989-90. PubMed ID: 11976227
[No Abstract] [Full Text] [Related]
38. Time to rehospitalization in patients with bipolar I disorder on lithium or valproate with adjunctive antipsychotics.
Lin CH; Huang CW; Chen CC; Hsu YF; Chang WH; Lane HY
Psychopharmacology (Berl); 2008 Oct; 200(2):301-3. PubMed ID: 18566801
[No Abstract] [Full Text] [Related]
39. Reducing the rehospitalization risk after a manic episode: A population based cohort study of lithium, valproate, olanzapine, quetiapine and aripiprazole in monotherapy and combinations.
Wingård L; Bodén R; Brandt L; Tiihonen J; Tanskanen A; Kieler H; Andersen M; Reutfors J
J Affect Disord; 2017 Aug; 217():16-23. PubMed ID: 28364619
[TBL] [Abstract][Full Text] [Related]
40. Mood stabilisers and risk of stroke in bipolar disorder.
Chen PH; Tsai SY; Pan CH; Chang CK; Su SS; Chen CC; Kuo CJ
Br J Psychiatry; 2019 Jul; 215(1):409-414. PubMed ID: 30295208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
